Cargando…

Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study

BACKGROUND: Hyperkalaemia is an electrolyte abnormality associated with adverse clinical outcomes; however, few studies have investigated the relationship with patterns of hyperkalaemia over time. This study explored the impact of time spent in a hyperkalaemic state and variability of serum potassiu...

Descripción completa

Detalles Bibliográficos
Autores principales:	James, Glen, Kim, Jennifer, Mellström, Carl, Ford, Kerrie L, Jenkins, Nia C, Tsang, Carmen, Evans, Marc, McEwan, Phil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967671/ https://www.ncbi.nlm.nih.gov/pubmed/35371436 http://dx.doi.org/10.1093/ckj/sfab225

Ejemplares similares

Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden
por: Tafesse, Eskinder, et al.
Publicado: (2020)

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
por: Furuland, Hans, et al.
Publicado: (2018)

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
por: Gordon, Jason, et al.
Publicado: (2018)

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
por: Linde, Cecilia, et al.
Publicado: (2019)

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database
por: Haase, Christiane Lundegaard, et al.
Publicado: (2021)

Body mass index and risk of obesity‐related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database
por: Haase, Christiane L., et al.
Publicado: (2020)

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
por: Bennett, Hayley, et al.
Publicado: (2014)

Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study
por: Neri, Luca, et al.
Publicado: (2012)

Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study
por: Pockett, Rhys D., et al.
Publicado: (2015)

The Cardiorenal Syndrome
por: Rosner, Mitchell H., et al.
Publicado: (2011)

Cardiorenal syndrome
por: Schetz, Miet
Publicado: (2009)

Cardiorenal syndrome
por: Ye, Wen Qing Wendy, et al.
Publicado: (2023)

What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right Patient
por: Strain, W. David, et al.
Publicado: (2020)

Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009
por: Meier, Geneviève C., et al.
Publicado: (2020)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
por: McEwan, Phil, et al.
Publicado: (2022)

Cardiorenal Syndromes and Sepsis
por: Chelazzi, C., et al.
Publicado: (2011)

Biomarkers in Cardiorenal Syndromes
por: Fu, Shihui, et al.
Publicado: (2018)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

The Diabetic Cardiorenal Nexus
por: D’Elia, John A., et al.
Publicado: (2022)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
por: Pochopien, Michal, et al.
Publicado: (2019)

Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
por: Strain, W. David, et al.
Publicado: (2019)

The Cardiorenal Effects of Piper amalago Are Mediated by the Nitric Oxide/Cyclic Guanosine Monophosphate Pathway and the Voltage-Dependent Potassium Channels
por: Monteiro, Luciane M., et al.
Publicado: (2023)

N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2
por: Ma, Mingming, et al.
Publicado: (2021)

Risk factors and outcome variables of cardiorenal syndrome type 1 from the nephrologist’s perspective
por: Seckinger, Dominik, et al.
Publicado: (2021)

Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example
por: Shiri, Tinevimbo, et al.
Publicado: (2021)

The Cardiorenal Syndrome: Making the Connection
por: Viswanathan, Gautham, et al.
Publicado: (2010)

The Cardiorenal Syndrome: A Review
por: Shah, B. N., et al.
Publicado: (2010)

Pharmacological Management of Cardiorenal Syndromes
por: House, Andrew A., et al.
Publicado: (2011)

Effects of Statins on Cardiorenal Syndrome
por: Yagi, Shusuke, et al.
Publicado: (2012)

Cardiorenal Syndromes: Pathophysiology to Prevention
por: McCullough, Peter A.
Publicado: (2010)

Cardiorenal Safety of OTC Analgesics
por: White, William B., et al.
Publicado: (2018)

Cardiorenal syndrome in thalassemia patients
por: Makmettakul, Sorasak, et al.
Publicado: (2020)

Range of adiposity and cardiorenal syndrome
por: Pazos, Fernando
Publicado: (2020)

Cardiorenal syndrome in COVID-19
por: Ali, Uzair Akbar, et al.
Publicado: (2021)

Cardiorenal Interactions: A Review
por: Verma, Sanam, et al.
Publicado: (2022)

Cardiorenal Syndrome: Ebony and Ivory
por: Florens, Nans
Publicado: (2023)

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
por: Evans, Marc, et al.
Publicado: (2012)

Risk Factors and Outcome Variables of Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients
por: She, Chang-Shou, et al.
Publicado: (2022)

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom
por: Gordon, Jason, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6gm2muhq2nhltc1fi0c95lvlac